(Press-News.org) Contact information: Heath McCoy
hjmccoy@ucalgary.ca
403-220-5089
University of Calgary
Researcher says extensive use of antibiotics in agriculture creating public health crisis
University of Calgary's Aidan Hollis advocates user fees on non-human antibiotics use
Citing an overabundance in the use of antibiotics by the agriculture and aquaculture industries that poses a threat to public health, economics professor Aidan Hollis has proposed a solution in the form of user fees on the non-human use of antibiotics.
In a newly released paper published in the New England Journal of Medicine, Hollis and co-author Ziana Ahmed state that in the United States 80 per cent of the antibiotics in the country are consumed in agriculture and aquaculture for the purpose of increasing food production.
This flood of antibiotics released into the environment – sprayed on fruit trees and fed to the likes of livestock, poultry and salmon, among other uses – has led bacteria to evolve, Hollis writes. Mounting evidence cited in the journal shows resistant pathogens are emerging in the wake of this veritable flood of antibiotics – resulting in an increase in bacteria that is immune to available treatments.
If the problem is left unchecked, this will create a health crisis on a global scale, Hollis says.
Hollis suggest that the predicament could be greatly alleviated by imposing a user fee on the non-human uses of antibiotics, similar to the way in which logging companies pay stumpage fees and oil companies pay royalties.
"Modern medicine relies on antibiotics to kill off bacterial infections," explains Hollis. "This is incredibly important. Without effective antibiotics, any surgery – even minor ones – will become extremely risky. Cancer therapies, similarly, are dependent on the availability of effective antimicrobials. Ordinary infections will kill otherwise healthy people."
Bacteria that can effectively resist antibiotics will thrive, Hollis adds, reproducing rapidly and spreading in various ways.
"It's not just the food we eat," he says. "Bacteria is spread in the environment; it might wind up on a doorknob. You walk away with the bacteria on you and you share it with the next person you come into contact with. If you become infected with resistant bacteria, antibiotics won't provide any relief."
While the vast majority of antibiotic use has gone towards increasing productivity in agriculture, Hollis asserts that most of these applications are of "low value."
"It's about increasing the efficiency of food so you can reduce the amount of grain you feed the cattle," says Hollis. "It's about giving antibiotics to baby chicks because it reduces the likelihood that they're going to get sick when you cram them together in unsanitary conditions.
"These methods are obviously profitable to the farmers, but that doesn't mean it's generating a huge benefit. In fact, the profitability is usually quite marginal.
"The real value of antibiotics is saving people from dying. Everything else is trivial."
While banning the use of antibiotics in food production is challenging, establishing a user fee makes good sense, according to Hollis.
Such a practice would deter the low-value use of antibiotics, with higher costs encouraging farmers to improve their animal management methods and to adopt better substitutes for the drugs, such as vaccinations.
Hollis also suggests that an international treaty could ideally be imposed. "Resistant bacteria do not respect national borders," he says. He adds that such a treaty might have a fair chance of attaining international compliance, as governments tend to be motivated by revenue collection.
Hollis notes that in the U.S., a move has been made to control the non-human use of antibiotics, with the FDA recently seeking voluntary limits on the use of antibiotics for animal growth promotion on farms.
He asks: "Is the Canadian government going to take any action to control the use of antibiotics for food production purposes? Health Canada is trying to monitor the use of antibiotics, but has virtually no control over use."
INFORMATION:
Researcher says extensive use of antibiotics in agriculture creating public health crisis
University of Calgary's Aidan Hollis advocates user fees on non-human antibiotics use
2013-12-27
ELSE PRESS RELEASES FROM THIS DATE:
Rheumatoid arthritis research shows the potential of large-scale genetic studies for drug discovery
2013-12-27
Rheumatoid arthritis research shows the potential of large-scale genetic studies for drug discovery
The results of the largest international study to date into the genetic basis of rheumatoid arthritis shed light on the biology of the disease and provide evidence that large-scale genetic ...
Special topic: Airworthiness and fatigue
2013-12-27
Special topic: Airworthiness and fatigue
Aviation safety is the theme given to the International Conference on Airworthiness and Fatigue: 7th ICSAELS Series Conference, Beijing, China, held on 25 March, 2013. This event was initiated by the International Center of ...
Molecular markers used for assessment of early sciatic nerve injury
2013-12-27
Molecular markers used for assessment of early sciatic nerve injury
Substance P and calcitonin gene-related peptide are the main neuropeptides in peripheral nerve ganglia, which can anterogradely transmit nociceptive information to the central nervous system. In ...
Genetic discovery points the way to much bigger yields in tomato, other flowering food plants
2013-12-27
Genetic discovery points the way to much bigger yields in tomato, other flowering food plants
Scientists learn how tweaking a 'hybrid vigor' gene generates higher crop yields
Cold Spring Harbor, NY – Every gardener knows the look of a ripe tomato. That bright ...
Building a better malaria vaccine: Mixing the right cocktail
2013-12-27
Building a better malaria vaccine: Mixing the right cocktail
A safe and effective malaria vaccine is high on the wish list of most people concerned with global health. Results published on December 26 in PLOS Pathogens suggest how a leading vaccine ...
Gene therapy for human skin disease produces long-term benefits
2013-12-27
Gene therapy for human skin disease produces long-term benefits
Stem cell-based gene therapy holds promise for the treatment of devastating genetic skin diseases, but the long-term clinical outcomes of this approach have been unclear. In a study online December 26th in the ...
The fate of the eels
2013-12-27
The fate of the eels
GEOMAR scientists prove oceanographic influences on eel recruitment
Smoked, fried or boiled - the European eel (Anguilla anguilla) has always been a popular fish in Europe. Even though people have consumed it for millennia, the origin ...
Are concussions related to Alzheimer's disease?
2013-12-27
Are concussions related to Alzheimer's disease?
MINNEAPOLIS – A new study suggests that a history of concussion involving at least a momentary loss of consciousness may be related to the buildup of Alzheimer's-associated plaques in the brain. The research ...
Surgery beats chemotherapy for tongue cancer, U-M study finds
2013-12-27
Surgery beats chemotherapy for tongue cancer, U-M study finds
ANN ARBOR, Mich. — Patients with tongue cancer who started their treatment with a course of chemotherapy fared significantly worse than patients who received surgery first, according ...
Researchers point to digital gains in human recognition
2013-12-27
Researchers point to digital gains in human recognition
Human beings are highly efficient at recognising familiar faces, even from very poor quality images.
New research led by a psychologist at the University of York is using advances in the level of detail ...
LAST 30 PRESS RELEASES:
New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients
Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds
COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC
CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC
Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital
New medication lowered hard-to-control high blood pressure in people with chronic kidney disease
Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment
New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment
Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor
Study prompts new theory of human-machine communication
New method calculates rate of gene expression to understand cell fate
Researchers quantify rate of essential evolutionary process in the ocean
Innovation Crossroads companies join forces, awarded U.S. Air Force contract
Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations
Pioneering advances in in vivo CAR T cell production
Natural medicines target tumor vascular microenvironment to inhibit cancer growth
Coral-inspired pill offers a new window into the hidden world of the gut
nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high
When getting a job makes you go hungry
Good vibrations could revolutionize assisted reproductive technology
More scrutiny of domestic fishing fleets at ports could help deter illegal fishing
Scientists transform plastic waste into efficient CO2 capture materials
Discovery of North America’s role in Asia’s monsoons offers new insights into climate change
MD Anderson and Phoenix SENOLYTIX announce strategic cross-licensing agreement to enhance inducible switch technologies for cell and gene therapies
Researchers discover massive geo-hydrogen source to the west of the Mussau Trench
Even untouched ecosystems are losing insects at alarming rates, new study finds
Adaptive visible-infrared camouflage with wide-range radiation control for extreme ambient temperatures
MD Anderson research highlights for September 5, 2025
Physicists create a new kind of time crystal that humans can actually see
Reminder: Final media invitation for EPSC-DPS2025 and details of media briefings on RAMSES and Juno missions
[Press-News.org] Researcher says extensive use of antibiotics in agriculture creating public health crisisUniversity of Calgary's Aidan Hollis advocates user fees on non-human antibiotics use